ODI Pharma AB (ODI.ST)

SEK 2.76

(-8.0%)

Operating Expenses Summary of ODI Pharma AB

  • ODI Pharma AB's latest annual operating expenses in 2023 was -5.00 SEK , down -100.0% from previous year.
  • ODI Pharma AB's latest quarterly operating expenses in 2023 FY was -5.00 SEK , down -100.0% from previous quarter.
  • ODI Pharma AB reported a annual operating expenses of 375 Thousand SEK in annual operating expenses 2022, down -94.72% from previous year.
  • ODI Pharma AB reported a annual operating expenses of 7.1 Million SEK in annual operating expenses 2021, up 81.29% from previous year.
  • ODI Pharma AB reported a quarterly operating expenses of 1.13 Million SEK for 2023 Q3, up 202.11% from previous quarter.
  • ODI Pharma AB reported a quarterly operating expenses of 1.28 Million SEK for 2023 Q1, down -32.23% from previous quarter.

Annual Operating Expenses Chart of ODI Pharma AB (2023 - 2018)

Historical Annual Operating Expenses of ODI Pharma AB (2023 - 2018)

Year Operating Expenses Operating Expenses Growth
2023 -5.00 SEK -100.0%
2022 375 Thousand SEK -94.72%
2021 7.1 Million SEK 81.29%
2020 3.91 Million SEK -16.71%
2019 4.7 Million SEK 36.03%
2018 3.45 Million SEK 0.0%

Peer Operating Expenses Comparison of ODI Pharma AB

Name Operating Expenses Operating Expenses Difference
AcuCort AB 13.24 Million SEK 100.0%
AlzeCure Pharma AB (publ) 38.26 Million SEK 100.0%
BioGaia AB (publ) 507.08 Million SEK 100.0%
Enzymatica AB (publ) 79.92 Million SEK 100.0%
Enorama Pharma AB (publ) 38.22 Million SEK 100.0%
Gabather AB (publ) 9.47 Million SEK 100.0%
Klaria Pharma Holding AB (publ.) 14.88 Million SEK 100.0%
Moberg Pharma AB (publ) 27.46 Million SEK 100.0%
Nanexa AB (publ) 135.78 Million SEK 100.0%
Newbury Pharmaceuticals AB (publ) 30.11 Million SEK 100.0%
Orexo AB (publ) 659.4 Million SEK 100.0%
Probi AB (publ) 208.93 Million SEK 100.0%
Swedencare AB (publ) 1.12 Billion SEK 100.0%
Swedish Orphan Biovitrum AB (publ) 9.39 Billion SEK 100.0%
Toleranzia AB 6.97 Million SEK 100.0%
Vivesto AB 355.71 Million SEK 100.0%